PriceTargets.com logo

MedEquities Realty Trust - MRT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.90
  • Forecasted Upside: -55.88%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$2.04 As of 09/11/2024 01:00 AM ET
▲ +0.11 (5.70%)
Get New MedEquities Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MRT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MRT

Analyst Price Target is $0.90
▼ -55.88% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for MedEquities Realty Trust in the last 3 months. The average price target is $0.90, with a high forecast of $0.90 and a low forecast of $0.90. The average price target represents a -55.88% upside from the last price of $2.04.

This chart shows the closing price for MRT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in MedEquities Realty Trust.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/19/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/17/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/16/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/15/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/12/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/29/2023Cantor FitzgeraldInitiated CoverageOverweight$0.90N/A
(Data available from 9/12/2019 forward)

News Sentiment Rating

1.02 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/15/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/16/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/15/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/15/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/14/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/13/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/12/2024

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

MedEquities Realty Trust logo
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.
Read More

Today's Range

Now: $2.04
Low: $1.93
High: $2.23

50 Day Range

MA: $11.03
Low: $11.03
High: $11.03

52 Week Range

Now: $2.04
Low: $6.27
High: $11.85

Volume

122,523 shs

Average Volume

215,758 shs

Market Capitalization

$116.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.45

Frequently Asked Questions

What sell-side analysts currently cover shares of MedEquities Realty Trust?

The following Wall Street analysts have issued reports on MedEquities Realty Trust in the last year: Cantor Fitzgerald.
View the latest analyst ratings for MRT.

What is the current price target for MedEquities Realty Trust?

1 Wall Street analysts have set twelve-month price targets for MedEquities Realty Trust in the last year. Their average twelve-month price target is $0.90, suggesting a possible downside of 55.9%. Cantor Fitzgerald has the highest price target set, predicting MRT will reach $0.90 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $0.90 for MedEquities Realty Trust in the next year.
View the latest price targets for MRT.

What is the current consensus analyst rating for MedEquities Realty Trust?

MedEquities Realty Trust currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MRT will outperform the market and that investors should add to their positions of MedEquities Realty Trust.
View the latest ratings for MRT.

What other companies compete with MedEquities Realty Trust?

Other companies that are similar to MedEquities Realty Trust include Zoomcar, Getaround, HyreCar, U-Haul and Ryder System. Learn More about companies similar to MedEquities Realty Trust.

How do I contact MedEquities Realty Trust's investor relations team?

MedEquities Realty Trust's physical mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider's listed phone number is 615-627-4710 and its investor relations email address is [email protected]. The official website for MedEquities Realty Trust is www.medequities.com. Learn More about contacing MedEquities Realty Trust investor relations.